Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial.

Blandine Gatta CherifiKamel MohammediTanguy CariouChristine Poitou Philippe A Touraine Gerald Raverot Thierry Brue Philippe ChansonFrédéric IllouzSolange GrunenwaldOlivier ChabreEmmanuel SonnetThomas CunyJerôme BertheratSébastien CzernichowEric Frison Antoine Tabarin

Published in: European journal of endocrinology (2024)

Combined with intensive lifestyle interventions, a 26-week treatment with exenatide was not demonstrated superior to placebo to treat craniopharyngioma-related obesity.

Keyphrases

weight loss
double blind
bariatric surgery
roux en y gastric bypass
placebo controlled
metabolic syndrome
gastric bypass
physical activity
insulin resistance
weight gain
phase iii
glycemic control
clinical trial
type diabetes
obese patients
randomized controlled trial
high fat diet induced
study protocol